dc.creator | Carvajal F. | |
dc.creator | Alcaraz-Iborra M. | |
dc.creator | Lerma-Cabrera J.M. | |
dc.creator | Valor L.M. | |
dc.creator | de la Fuente L. | |
dc.creator | Sanchez-Amate M.D.C. | |
dc.creator | Cubero I. | |
dc.date.accessioned | 2020-09-02T22:14:16Z | |
dc.date.accessioned | 2022-11-08T20:20:47Z | |
dc.date.available | 2020-09-02T22:14:16Z | |
dc.date.available | 2022-11-08T20:20:47Z | |
dc.date.created | 2020-09-02T22:14:16Z | |
dc.date.issued | 2015 | |
dc.identifier | 287, , 230-237 | |
dc.identifier | 01664328 | |
dc.identifier | https://hdl.handle.net/20.500.12728/3938 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143745 | |
dc.language | en | |
dc.publisher | Elsevier | |
dc.subject | Drinking in the dark (DID) | |
dc.subject | Ethanol binge-like consumption | |
dc.subject | Ethanol sedation | |
dc.subject | Orexins | |
dc.subject | OX receptor 1 | |
dc.subject | 1 (2 methyl 6 benzoxazolyl) 3 (1,5 naphthyridin 4 yl)urea | |
dc.subject | alcohol | |
dc.subject | orexin 1 receptor | |
dc.subject | saccharin | |
dc.subject | 1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea | |
dc.subject | alcohol | |
dc.subject | alcohol blood level | |
dc.subject | benzoxazole derivative | |
dc.subject | central depressant agent | |
dc.subject | drinking water | |
dc.subject | hypnotic sedative agent | |
dc.subject | messenger RNA | |
dc.subject | orexin receptor | |
dc.subject | orexin receptor antagonist | |
dc.subject | saccharin | |
dc.subject | urea | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | Article | |
dc.subject | binge drinking | |
dc.subject | controlled study | |
dc.subject | drinking behavior | |
dc.subject | drug activity | |
dc.subject | food intake | |
dc.subject | homeostasis | |
dc.subject | latent period | |
dc.subject | lateral hypothalamus | |
dc.subject | locomotion | |
dc.subject | male | |
dc.subject | metabolism | |
dc.subject | mouse | |
dc.subject | nonhuman | |
dc.subject | pathogenesis | |
dc.subject | priority journal | |
dc.subject | protein expression | |
dc.subject | repeated drug dose | |
dc.subject | righting reflex | |
dc.subject | sedation | |
dc.subject | signal transduction | |
dc.subject | alcohol blood level | |
dc.subject | analogs and derivatives | |
dc.subject | animal | |
dc.subject | binge drinking | |
dc.subject | C57BL mouse | |
dc.subject | drug effects | |
dc.subject | drug therapy | |
dc.subject | eating | |
dc.subject | metabolism | |
dc.subject | physiology | |
dc.subject | reflex | |
dc.subject | Animals | |
dc.subject | Benzoxazoles | |
dc.subject | Binge Drinking | |
dc.subject | Blood Alcohol Content | |
dc.subject | Central Nervous System Depressants | |
dc.subject | Drinking Water | |
dc.subject | Eating | |
dc.subject | Ethanol | |
dc.subject | Hypnotics and Sedatives | |
dc.subject | Hypothalamic Area, Lateral | |
dc.subject | Locomotion | |
dc.subject | Male | |
dc.subject | Mice, Inbred C57BL | |
dc.subject | Orexin Receptor Antagonists | |
dc.subject | Orexin Receptors | |
dc.subject | Reflex | |
dc.subject | RNA, Messenger | |
dc.subject | Saccharin | |
dc.subject | Urea | |
dc.title | Orexin receptor 1 signaling contributes to ethanol binge-like drinking: Pharmacological and molecular evidence | |
dc.type | Article | |